This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1986;29(6):739-41.

doi: 10.1007/BF00615971.

Single-dose quinidine treatment inhibits metoprolol oxidation in extensive metabolizers

T Leemann, P Dayer, U A Meyer

PMID: 3709620
DOI: 10.1007/BF00615971

Single-dose quinidine treatment inhibits metoprolol oxidation in extensive metabolizers

T Leemann et al. Eur J Clin Pharmacol. 1986.

. 1986;29(6):739-41.

doi: 10.1007/BF00615971.

Authors

T Leemann, P Dayer, U A Meyer

PMID: 3709620
DOI: 10.1007/BF00615971

No abstract available

PubMed Disclaimer

Similar articles

Single-dose quinidine treatment inhibits mexiletine oxidation in extensive metabolizers of debrisoquine.
Broly F, Vandamme N, Caron J, Libersa C, Lhermitte M. Broly F, et al. Life Sci. 1991;48(26):PL123-8. doi: 10.1016/0024-3205(91)90618-l. Life Sci. 1991. PMID: 2046473
Use of quinidine inhibition to define the role of the sparteine/debrisoquine cytochrome P450 in metoprolol oxidation by human liver microsomes.
Otton SV, Crewe HK, Lennard MS, Tucker GT, Woods HF. Otton SV, et al. J Pharmacol Exp Ther. 1988 Oct;247(1):242-7. J Pharmacol Exp Ther. 1988. PMID: 3171974
Differential stereoselective metabolism of metoprolol in extensive and poor debrisoquin metabolizers.
Lennard MS, Tucker GT, Silas JH, Freestone S, Ramsay LE, Woods HF. Lennard MS, et al. Clin Pharmacol Ther. 1983 Dec;34(6):732-7. doi: 10.1038/clpt.1983.242. Clin Pharmacol Ther. 1983. PMID: 6641087
The polymorphic oxidation of beta-adrenoceptor antagonists. Clinical pharmacokinetic considerations.
Lennard MS, Tucker GT, Woods HF. Lennard MS, et al. Clin Pharmacokinet. 1986 Jan-Feb;11(1):1-17. doi: 10.2165/00003088-198611010-00001. Clin Pharmacokinet. 1986. PMID: 2868819 Review.
Clinical implications of the competitive inhibition of the debrisoquin-metabolizing isozyme by quinidine.
Caporaso NE, Shaw GL. Caporaso NE, et al. Arch Intern Med. 1991 Oct;151(10):1985-92. Arch Intern Med. 1991. PMID: 1681790 Review.

See all similar articles

Cited by

Antiarrhythmic agents: drug interactions of clinical significance.
Trujillo TC, Nolan PE. Trujillo TC, et al. Drug Saf. 2000 Dec;23(6):509-32. doi: 10.2165/00002018-200023060-00003. Drug Saf. 2000. PMID: 11144659 Review.
A discordance between cytochrome P450 2D6 genotype and phenotype in patients undergoing methadone maintenance treatment.
Shiran MR, Chowdry J, Rostami-Hodjegan A, Ellis SW, Lennard MS, Iqbal MZ, Lagundoye O, Seivewright N, Tucker GT. Shiran MR, et al. Br J Clin Pharmacol. 2003 Aug;56(2):220-4. doi: 10.1046/j.1365-2125.2003.01851.x. Br J Clin Pharmacol. 2003. PMID: 12895196 Free PMC article.
The pharmacology of tramadol.
Dayer P, Collart L, Desmeules J. Dayer P, et al. Drugs. 1994;47 Suppl 1:3-7. doi: 10.2165/00003495-199400471-00003. Drugs. 1994. PMID: 7517823 Review.
Sparteine oxidation is practically abolished in quinidine-treated patients.
Brinn R, Brøsen K, Gram LF, Haghfelt T, Otton SV. Brinn R, et al. Br J Clin Pharmacol. 1986 Aug;22(2):194-7. doi: 10.1111/j.1365-2125.1986.tb05250.x. Br J Clin Pharmacol. 1986. PMID: 3756067 Free PMC article.
Debrisoquine oxidative phenotyping and psychiatric drug treatment.
Derenne F, Joanne C, Vandel S, Bertschy G, Volmat R, Bechtel P. Derenne F, et al. Eur J Clin Pharmacol. 1989;36(1):53-8. doi: 10.1007/BF00561023. Eur J Clin Pharmacol. 1989. PMID: 2563689

See all "Cited by" articles

References

1. FEBS Lett. 1984 Aug 6;173(2):287-90 - PubMed
1. Eur J Drug Metab Pharmacokinet. 1982 Jan-Mar;7(1):73-7 - PubMed
1. Life Sci. 1980 Nov 3;27(18):1673-7 - PubMed
1. Life Sci. 1984 Jan 2;34(1):73-80 - PubMed
1. Arzneimittelforschung. 1977;27(96):1836-44 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Springer
Other Literature Sources
- The Lens - Patent Citations Database